TABLE 3.
Cumulative probability of retention in the ART program throughout the follow-up period by sex of 23,686 HIV-infected patients who initiated antiretroviral therapy between September 2007 and April 2020 in 9 large-volume care sites (Conakry and Nzérékoré, Guinea. 2021).
| Follow-up time | Total | Women | Man | |||
|---|---|---|---|---|---|---|
| Number of patients at risk | Percent (95% CI) | Number of patients at risk | Percent (95% CI) | Number of patients at risk | Percent (95% CI) | |
| 6 months | 22,566 | 86.0 (85.1–86.8) | 15,595 | 87.6 (87.2–87.8) | 6,971 | 84.3 (84.03–84.76) |
| 1 year | 19,093 | 76.2 (76.1–77.2) | 13,305 | 78.7 (78.2–78.9) | 5,789 | 73.1 (72.61–73.79) |
| 2 years | 14,244 | 70.2 (69.3–71.6) | 10,067 | 73.2 (72.6–73.5) | 4,177 | 67.1 (66.52–67.62) |
| 3 years | 11,578 | 66.5 (65.7–68.2) | 8,221 | 70.2 (69.5–70.3) | 3,357 | 64.0 (63.52–64.69) |
| 4 years | 9,108 | 64.0 (62.7–65.6) | 6,511 | 67.6 (65.8–67.8) | 2,597 | 61.4 (60.7–62.23) |
| 5 years | 7,113 | 61.3 (60.4–62.9) | 5,121 | 65.2 (63.9–65.7) | 1,993 | 58.5 (58.01–59.5) |
| 6 years | 5,691 | 58.4 (57.9–61.4) | 4,127 | 62.7 (62.1–63.7) | 1,565 | 55.4 (55.1–57.2) |
| 7 years | 4,714 | 55.8 (58.9–59.7) | 3,401 | 61.6 (60.8–61.9) | 1,313 | 54.4 (53.6–55.2) |
| 8 years | 3,828 | 54.7 (53.1–56.7) | 2,760 | 60.2 (58.5–62.3) | 1,068 | 52.7 (52.0–53.8) |
| 9 years | 2,906 | 54.4 (53.6–55.9) | 2,079 | 58.1 (57.4–58.7) | 828 | 50.8 (48.9–52.9) |
| 10 years | 2,315 | 53.6 (53.1–54.5) | 1,668 | 57.1 (55.8–56.7) | 648 | 48.9 (48.5–50.4) |
| 11 years | 1,769 | 53.0 (52.2–53.4) | 1,275 | 55.7 (54.2–55.3) | 6,971 | 48.2 (47.3–49.2) |
| 12 years | 965 | 50.0 (49.8–51.5) | 685 | 54.1 (53.2–54.5) | 5,789 | 46.1 (45.0–47.8) |
| 13 years | 194 | 48.0 (47.1–50.9) | 136 | 53.5 (52.4–53.9) | 4,177 | 42.9 (41.5–45.6) |
CI, confidence interval.